| Trial Identifier: | D8820C00002 |
| Sponsor: | AstraZeneca |
| Start Date: | June 2024 |
| Primary Completion Date: | October 2025 |
| Study Completion Date: | October 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, AL | Anniston, AL, US, 36207 |
| US, CA | Glendale, CA, US, 91206 |
| US, MD | Baltimore, MD, US, 21225 |
| US, TX | San Antonio, TX, US, 78229 |